Name

Patient	Age	Sex	Distribution of rash	Agent	Management	Outcome	Course of Illness
1	68	M	Generalised	Dilantin	-Removal of agent -IV hydrocortisone	Rash improved on day 5	Recovered on day 12
2	22	F	Face,lips,trunk with pustules	Unknown	-Removal of agent -IV hydrocortisone, IVIG, Klacid -Topical elomet lotion	Shortness of breath, required prophylactic intubation in ICU	Recovered on day 21
3	51	F	Face, limbs, perioral, perineum, sole and palm	Ciproxin, NSAID	-Removal of agent -IV hydrocortisone	Rash improved on day 5	Recovered on day 18
4	40	M	Perioral, Conjunctiva,Buccal mucosa	Acyclovir	-Removal of agent -IV hydrocortisone, -Topical Elomet, thymol gargle, Nadexin eye drop	Fever and rash started to improve on day 6	Recovered on day 16
5	32	F	Haemorrhagic spots over the face,lips, buccal mucosa and generalised MP rash.	Acyclovir , Tegretol	-Removal of agent -Oral prednisolone, -Topical Daktacort, difflam mouthwash	Fever and rash improved on day 7	Recovered on day 17
6	46	F	Generalised MP rash and buccal mucosa haemorrhagic spots	Augmentin,Allopurinol	-Removal of agent -IV hydrocortisone, Klacid	Fever and rash improved on day 4	Subsided on day 17
7	65	M	Truncal MP rash and mucosa ulcer	Cloxacillin, Ticlid	-Removal of agent -IV hydrocortisone, Acyclovir -Topical Synalar	Rash improved on day 3	Subsided on day 14

Table 1. Summary of details of patients treated at United Christian Hospital between 2001-2002. It may be noticed that the common causative agent is drug-induced. SJS commonly occurs in adults age>40. Male and female are equally affected. The rash usually starts improving on day 4-5 upon the routine treatment, i.e., IV corticosteroid. Most of our patients require more than 14 days to have their rash totally subsided.